Abrdn PLC Novartis Ag Transaction History

Abrdn PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$92.27 - $101.54 $3.51 Million - $3.87 Million	38,071 New	38,071 $3.84 Million
Q4 2019 Feb 18, 2020	SELL	$84.35 - $95.37 $455,489 - $514,998	-5,400 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $13.6 Million - $15.5 Million	-180,100 Reduced 97.09%	5,400 $519,000
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $110,490 - $123,030	-1,500 Reduced 0.8%	185,500 $15.6 Million
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $2.92 Million - $3.38 Million	-43,600 Reduced 18.91%	187,000 $16.1 Million
Q2 2018 Aug 09, 2018	BUY	$64.91 - $73.36 $14.5 Million - $16.4 Million	223,200 Added 3016.22%	230,600 $17.4 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $28,932 - $31,056	400 Added 5.71%	7,400 $621,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $518,980 - $540,890	7,000	7,000 $601,000

1,423

130M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.